Scarica l'app Stockscreener
1.57
0.64%
0.01
Dopo l'orario di chiusura:
1.63
0.06
+3.82%
Proqr Therapeutics N V Borsa (PRQR) Ultime notizie
ProQR (PRQR) Eyes Next Move After Holiday Ahead of AX-0810 Data - Bez Kabli
ProQR Therapeutics Q1 2026 Earnings: Narrower Net Loss, No Revenue as Pipeline Progress Drives Stock GainsWall Street Picks - Newser
Cash per share of ProQR Therapeutics N.V. – LS:A12B97 - TradingView
PRQR Stock Price, Quote & Chart | PROQR THERAPEUTICS NV (NASDAQ:PRQR) - ChartMill
ProQR Therapeutics N.V. (PRQR) Presents at 29th ASGCT Annual Meeting 2026Slideshow - Seeking Alpha
ProQR Therapeutics N.V. (PRQR) Presents at TIDES USA 2026Slideshow (NASDAQ:PRQR) 2026-05-15 - Seeking Alpha
ProQR Therapeutics N.V.Ordinary Shares (NQ: PRQR - The Chronicle-Journal
ProQR Therapeutics N.V. (NASDAQ:PRQR) Analysts Just Slashed This Year's Revenue Estimates By 22% - Yahoo Finance
ProQR Therapeutics Releases Q1 2026 Financial Results - AlphaStreet
ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances - TipRanks
ProQR Posts Wider Q1 2026 Loss but Maintains Strong Cash Position - TipRanks
ProQR Announces First Quarter 2026 Operating and Financial Results - The Manila Times
ProQR (Nasdaq: PRQR) Q1 2026 results, Axiomer pipeline and cash runway - Stock Titan
ProQR (Nasdaq: PRQR) updates AX-0810 strategy and Q1 2026 results - Stock Titan
ProQR Therapeutics N.V. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform - The Manila Times
ProQR Announces Multiple Upcoming Scientific Conference - GlobeNewswire
MSN Money - MSN
Number of shareholders of ProQR Therapeutics N.V. – LS:A12B97 - TradingView
ProQR Therapeutics (PRQR) to Release Quarterly Earnings on Thursday - MarketBeat
ProQR Sets June 2, 2026 Date for Annual General Meeting of Shareholders - The Globe and Mail
ProQR forms advisory board, partnership with Ginkgo as part of AI strategy - MSN
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 - markets.businessinsider.com
ProQR Therapeutics NV expected to post a loss of 12 cents a shareEarnings Preview - TradingView
ProQR Therapeutics N : AGM 2026 POA Registered Shareholders - marketscreener.com
ProQR sets June 2 shareholder meeting, posts agenda documents online - Stock Titan
ProQR (PRQR) 2026 AGM to expand share capital, issuance and buyback powers - Stock Titan
ProQR Announces Annual General Meeting of Shareholders to Be Held June 2, 2026 - Moomoo
ProQR Nominates Boehringer Ingelheim CMO Lykke Hinsch Gylvin to Board to Support Next Growth Phase - The Globe and Mail
ProQR nominates Boehringer Ingelheim executive to board - Investing.com UK
ProQR nominates Boehringer Ingelheim executive to board By Investing.com - Investing.com Australia
Boehringer exec tapped for ProQR (NASDAQ: PRQR) board nomination - Stock Titan
ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors - GlobeNewswire
ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Down 24.4% in April - MarketBeat
ProQR Therapeutics NV (MEX:PRQRN) Stock News, Headlines & Updates - GuruFocus
ProQR Therapeutics NV (MEX:PRQRN) Stock Price & 30 Year Financial Data - GuruFocus
Chardan Capital Maintains ProQR Therapeutics N.V. (PRQR) Buy Recommendation - MSN
ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
ProQR Therapeutics (NASDAQ:PRQR) Stock Price Passes Above 50 Day Moving AverageShould You Sell? - MarketBeat
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Retinitis Pigmentosa Market - openPR.com
0.98%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):